Nordic M&A Forum 2022

10 March, 6:00pm - 10:00pm

Linklaters, One Silk St, London EC2Y 8HQ

The Nordic M&A Forum 2022 will be discussing the year ahead for Nordic cross-border M&A and financing, and brings together stakeholders from across the industry, from banks, asset managers, private equity and advisory firms, from both the City and the Nordics.

About the forum

The Nordic M&A Forum is a yearly gathering bringing together stakeholders from across the industry, from banks, asset managers, private equity and advisory firms, from both the City and the Nordics.

See photos from Nordic M&A Forum 2020

Booking options

SCC member price: £45
YP member price: £45
Partner organisation price: £90
Non-member price: £135

Terms & Conditions

Bookings are non-refundable but at the discretion of the organiser, you can change the name of the person(s) attending. For this, please contact events@scc.org.uk. 

Essential information

Accessing the venue/event relating to Covid-19


The Swedish Chamber of Commerce is continually monitoring government and health guidelines to protect our team and our guests. Along with the venue provider, we want to provide a safe environment. All guests must comply with government recommendations and if you are feeling unwell or showing any symptoms, we kindly ask you to stay at home.

This event has passed

Agenda

Welcome

18.30

Gabriel Mellqvist, Reporter, Dagens industri and Master of Ceremonies

Peter Sandberg., Chief Executive, Swedish Chamber of Commerce

Data presentation

Dominick Mondesir, Senior Analyst, EMEA Private Capital, PitchBook

The state of the Nordic M&A markets

Are today’s valuations sustainable in a new inflation and interest environment? And is private equity still the growth engine for M&A in 2022? Are central bank policies a threat to the industry?

Nuala Higgins, Head of Private Equity, Carnegie Investment Bank

Pia Kåll, Managing Partner, CapMan Buyout

Jan Olsson., CEO of the Nordics, Deutsche Bank and Chairman, Swedish Chamber of Commerce

Hans Årstad, Private Equity Director, KKR

Fredrik Bolander, Managing Director, Lincoln International

The untapped growth potential in life science M&A

Healthcare corporate M&A deal value has dropped lately, but healthcare technology has massive and to some extent untapped growth potential. What is the future and opportunities for healthcare within M&A and how will the deal activity evolve in the Nordics during 2022?

Dr. Johan Christenson, Partner, HealthCap

Shaun Grady, Senior Vice President, Business Development Operations, AstraZeneca

Dr. Miao He, Senior Investment Associate, Hadean Ventures

Peter Lindell, Partner, Brunswick Group

Fireside chat: ESG - Where are we and where are we going?

Sarah Hempel, Head of Sustainability, Axcel

Richard Sissons, Client Development, DealCloud

Will tech continue being a driver for M&A?

Technology has historically shifted the focus of M&A, and has the power to future-proof businesses. The high amount of private tech unicorns in combination with what looked like a strong IPO pipeline globally expected to create further opportunities in 2022. What is the new outlook and what challenges lays ahead?

Sergio Ferrarini, Partner, Inflexion

Ola Nordbye, Venture & Growth Investments, Kinnevik

Ola Nordquist, Partner, Head of Nordics, Permira

Charlotte Levin, Global Partner, Linklaters

Confirmed speakers 2022

Fredrik Bolander

Fredrik Bolander

Managing Director, Lincoln International

Fredrik provides advisory services on mergers & acquisitions (M&A) in the Nordic region. He brings nearly two decades of experience working across industry groups with a particular focus on financial sponsors. Fredrik has originated and executed a large number of public and private M&A, equity capital market and financing transactions for Nordic and international financial sponsors. Prior to joining Lincoln, Fredrik was the Head of the Nordic Region for HNC Advisors AG. He also worked for Deutsche Bank in Stockholm and London as the Head of Nordic Financial Sponsors. Fredrik earned a Master of Science in business and economics from the Stockholm School of Economics.

Dr. Johan Christenson

Dr. Johan Christenson

Partner, HealthCap

Dr. Johan Christenson has been a Partner at HealthCap since 2001. He has been in the life science sector covering science, medicine, drug development and venture investments since 1981. Prior to joining HealthCap, Dr. Christenson was with SEB Företagsinvest (the venture capital arm of SEB) to supervise the health care portfolio. He was Global Product Director and member of the global therapy area management team of Pain and Inflammation at AstraZeneca. He has an MD degree and a PhD in basic neuroscience from Karolinska Institute. He held a position as Assistant Dean at the Karolinska Institute Graduate School for two years.

Sergio Ferrarini

Sergio Ferrarini

Partner, Inflexion

Sergio is a Partner focusing on technology, data and tech-enabled service businesses in Europe. Sergio started his career in the M&A team at Morgan Stanley in Milan, moving into private equity when he joined Bain Capital in London. There he was involved in several transactions in Europe and the US covering payments, technology and information services. He was then one of the founding members of the Principal Investing team at Eight Roads, the proprietary investing arm of Fidelity International, with a mandate to invest in growth companies with a focus on financial services and technology. Prior to joining Inflexion in 2019, Sergio worked for HgCapital, a private equity firm focused on software and service businesses.

Shaun Grady

Shaun Grady

Senior Vice President, Business Development Operations, AstraZeneca

Shaun Grady has global responsibility for Business Development Operations at AstraZeneca, leading the company’s transaction execution, due diligence and Alliance and Integration Management function including licensing and partnering, M&A, externalisation and divestments. Shaun was appointed to his current role in 2013. Prior to this, he was Vice President, Strategic Partnering & Business Development (2010 - 13) and Vice President, Corporate Business Development (2006 - 10). Shaun originally joined ICI as an attorney and held positions in the pharmaceuticals, petrochemicals, and legal departments. Following the demerger from ICI, he was appointed Assistant General Counsel, Corporate for Zeneca Group PLC. Shaun worked on the merger of Astra and Zeneca, the merger of Zeneca Agrochemicals with Novartis Agribusiness to form Syngenta, and the creation of Avecia. Shaun also worked on the acquisition of Cambridge Antibody Technology (CAT) and later MedImmune and led the acquisition of Amylin, and subsequent buy-out of Bristol-Myers’ Squibb’s interest in the AZ – BMS Diabetes Alliance. More recently Shaun led the transaction team for AZ’s global ADC collaborations with Daichi Sankyo for Enhertu and subsequently DS -1062. Shaun has led AZ’s recent Externalisation and divestment programme involving significant sell – side transactions with Pfizer, Aspen, Grunenthal, Cheplapharm, Atnahs, Juvise, Recordati and Covis. Shaun is a Fellow in Entrepreneurship at Cambridge University Judge Business School and a Fellow Commoner of Lucy Cavendish College, Cambridge. Shaun is also Chairman of the Board of Directors of Cambridge United Football Club, and a member of the Board at Cambridge Arts Theatre, Healx and Prostate Cancer Research Centre. Based in Cambridge, Shaun enjoys rugby and soccer, and occasionally turns his hand to sports writing. 

Dr. Miao He

Dr. Miao He

Senior Investment Associate, Hadean Ventures

Miao is a scientist by training and has worked in the life sciences industry for a decade in venture capital, startups and R&D. Previously she was an Associate at Luminous Ventures, a UK-based venture capital firm focusing on healthcare and other innovative technologies. Miao has worked as a Bioinformatics Scientist at Illumina, where she developed new algorithms for precision oncology applications and collaborated with Genomics England on the 100,000 Genomes Project in the UK. Miao has also worked in early-stage venture investing in Israel and has carried out consulting work for Cancer Research UK and healthcare startups.

Miao holds a PhD in Molecular Biology from the University of Cambridge and an MBA from London Business School. She has published 18 peer-reviewed publications in leading journals including Nature Genetics and PNAS.

Sarah Hempel

Sarah Hempel

Head of Sustainability, Axcel

Sarah Hempel joined Axcel in 2020 as Head of Sustainability. Sarah is responsible for addressing ESG in Axcel’s operations and portfolio companies as well as communicating and engaging with stakeholders on sustainability topics. Prior to joining Axcel Sarah served as the Head of Global Sustainability Strategy & Governance at Novozymes. Sarah has furthermore been employed at LEGO as Corporate Affairs manager and as a management consultant at McKinsey & Company. Sarah holds a MSc in International Business and Development Studies and a CEMS Master’s in Management from Copenhagen Business School. Sarah has also studied at HEC Paris.

Nuala Higgins

Nuala Higgins

Head of Private Equity, Carnegie Investment Bank

Nuala Higgins is Head of Private Equity at Carnegie Investment Bank. Nuala joined Carnegie's Stockholm office in 2011 and has more than 20 years' of banking experience. Before joining Carnegie, she have had experiences from both Danske Bank and AC Advisory. Nuala has been involved with M&A transactions such as Lift Systems, Doggy, Dellner, Evondos, EG, Greenfood, Happy Socks and many more. Nuala has also been involved with, amongst others the following IPO transactions: Hemnet, Actic, Bygghemma, Inwido, Karnov and Nordax Bank.

Pia Kåll

Pia Kåll

Managing Partner, CapMan Buyout

Pia joined CapMan Buyout in 2016 as a Partner and in June 2017 was elected Managing Partner. CapMan, established in 1989, is Nordic small and mid-market specialist. CapMan Buyout is currently investing from its 11th fund. Before joining CapMan Pia was a member of the Executive Board of Outotec and held the position of Senior Vice President Strategy, Marketing and Operational Excellence. Outotec is a listed company offering minerals and metals processing technology to the mining industry globally, with a revenue of 1,5-2 bn EUR and around 5000 employees. Prior to Outotec Pia was an Associate Principal at McKinsey&Company. She holds an M.Sc. In Engineering Physics and Mathematics.

Charlotte Levin

Charlotte Levin

Global Partner, Linklaters

Charlotte Levin recently joined Linklaters law firm as a global partner. Charlotte is based in the firm’s Stockholm office within the M&A Corporate practice. She has several years’ experience of M&A focusing on public takeovers, IPOs, capital raisings, public offerings and other capital markets transactions and from advising listed companies and their owners in all types of capital markets and corporate law issues.

Peter Lindell

Peter Lindell

Partner, Brunswick Group

Peter Lindell is a Partner at Brunswick Group and head of the Stockholm office. Peter advises on financial situations, corporate reputation and crisis. Peter is part of the FIG sector team and Brunswick’s M&A and investor engagement practices. Peter joined Brunswick in 2010 and has 20 years of experience advising boards, management and politicians on business critical issues. He spent three years at AMF Pension as head of corporate governance, prior to that he spent six years as a senior investment manager at the Ministry of Industry and has a background as journalist for Bloomberg news. Peter has recently worked on IPO:s of for example Nordnet and Hemnet, and advised on public to private transactions such as Nordax acquisition of Bank Norwegian, Nordic Capital’s acquisition of Innovalon, Triton’s acquisition of HiQ as well as for Veoneer in connection with the bid from SSW and Qualcomm.

Gabriel Mellqvist

Gabriel Mellqvist

Reporter, Dagens industri and Master of Ceremonies

Gabriel Mellqvist is a Swedish journalist working for Dagens industri. During his twelve year long career at the financial newspaper, he has for instance covered American business and politics as a New York correspondent, as well as worked as a UK Correspondent in London. He has previously anchored the TV-show Börslunch on Stockholm-based broadcaster EFN, Ekonomi- och Finansnyheterna. He has also worked for Reuters and has also co-authored the book United Stockholms of America.

Dominick Mondesir

Dominick Mondesir

Senior Analyst, EMEA Private Capital, PitchBook

Dominick Mondesir is a senior private capital analyst at PitchBook, where he covers private equity and M&A across the EMEA region. His research has been cited in several leading publications, including Sky News, City A.M. and Private Equity International. Prior to joining PitchBook, Mondesir was a senior investment banking associate at a boutique investment bank in Florida, where he specialized in providing advisory and capital raising services to clients in connection with private equity and debt placements. Mondesir holds an MBA in finance from the University of Tampa and a bachelor’s degree in economics with politics from Loughborough University. He is based in PitchBook’s London office. 

Ola Nordbye

Ola Nordbye

Venture & Growth Investments, Kinnevik

Ola is based in Kinnevik’s London office and leads their Financial and Business services investing. Before Kinnevik, Ola worked with growth investments in B2B companies across Europe for the UK based fund One Peak Partners. Prior to that, Ola spent 4 years as an M&A banker at J.P. Morgan in London, focused on the consumer and retail sectors. 

He is particularly passionate about how technology can make financial services accessible to under-served customer groups, and at lower cost. Ola is on the board as a director or observer across a range of companies, including tech businesses Monese and Sure. He is also an active angel investor.

Ola Nordquist

Ola Nordquist

Partner, Head of Nordics, Permira

Ola is Head of the Nordics at Permira, based in London. He has worked on a number of transactions including Grobest, Klarna, Pharmaq and TDC. Prior to joining Permira, Ola worked in London at Apax Partners on a number of buy-outs specifically covering the Nordic region, and in M&A at Lehman Brothers. Previously, he was a Manager in the Strategy Division at Andersen Consulting (now Accenture) in Washington DC. Ola has a Master’s in Economics from the Gothenburg School of Economics and Commercial Law, Sweden, and an MBA from Harvard Business School, USA.

Jan Olsson.

Jan Olsson.

CEO of the Nordics, Deutsche Bank and Chairman, Swedish Chamber of Commerce

Jan joined Deutsche Bank in 1988 and has held several positions within M&A, Structured Finance and Corporate Finance. He holds a BA from Pomona College, an MBA from Wharton, an MA from University of Pennsylvania, and a Graduate Diploma in Business Studies from the London School of Economics.

Peter Sandberg.

Peter Sandberg.

Chief Executive, Swedish Chamber of Commerce

Peter Sandberg is Chief Executive at the Swedish Chamber of Commerce since 2018. He holds an MSc in Political Science and Economics from Lund University and has previously worked in press and communications roles at the Swedish Embassy and Chamber of Commerce in London respectively. He has worked at the Swedish-American Chamber of Commerce in New York City as Director of Program and VP, and when returning to London, joined the British Private Equity & Venture Capital Association where he was part of the management team in his role as Director of Commercial Development & Membership.

Richard Sissons

Richard Sissons

Client Development, DealCloud

Richard Sissons serves as the Associate Director for Client Development at DealCloud, an Intapp company. He previously worked in KPMG’s Mobility 2030 team, and helped advise clients in the private and public sector on the future of mobility, particularly the mass adoption of electric and autonomous vehicles, the renewable energy transition, and the future of charging infrastructure. Sissons also previously worked in the Global Strategy Group at KPMG. Prior to that, he spent time in a private equity strategy team for MeDirect Group and as an analyst at UBS.

Hans Årstad

Hans Årstad

Private Equity Director, KKR

Hans Arstad joined KKR in 2014 and leads the European private equity activities across the Nordic region. Mr. Arstad has been involved in the investments in Sector Alarm, Söderberg & Partners, Välinge, iGas, Ambea, Mehilainen, Visma, Avida and Ocean Yield. Prior to joining KKR, he worked for McKinsey & Company. Mr. Arstad holds a M.Sc. in Finance and a B.Sc. in Business Administration from Norwegian School of Economics.

Highlights from the Nordic M&A Forum 2021

The Nordic M&A Forum brings together stakeholders from across the industry, from banks, asset managers, private equity and advisory firms, from both the City and the Nordics, to discuss the year ahead for M&A activity in the Nordics.

Keep in touch on social
A very warm welcome to our newest members! Ascension @Barclays @boardclic @CollectionCos @DoctrinAB @einrideofficial @closethackers @MinestoAB @RudPedersenG @Skillspark_HQ @StanChart Stockholms Bränneri @WhitecapConsult
SCC chief executive Peter Sandberg speaks about #Brexit in @sverigesradio , about UK, the current state and what to expect next. Tune in: https://t.co/DNmYnUIINI
Yesterday, we welcomed seven new members to our Board of Directors at our 115th Annual General Meeting. Learn more: https://t.co/2YFBlo10Px
Join our mailing list